NTHINasdaqPharmaceutical PreparationsFiscal year ends December 31
NEONC TECHNOLOGIES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.72+0.02 (+0.74%)
Close on Oct 19, 2026
- Market cap
- $67.09M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
12.2%
3M of 26M shares
Institutional holders
21
2 new, 8 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
30 buys · 1 sales
Net bought $1.46M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Amir F. Heshmatpour | 6,488,499 | 34.30% | 13D (active) | Mar 26, 2025 |
| Cinctive Capital Management LP | 2,483,980 | 9.99% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NTHI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cinctive Capital Management LP | 1,607,464 | 6.20% | $7.28M | +181,938 | 0.27% |
| Vanguard Capital Management LLC | 504,171 | 1.94% | $2.28M | +288,471 | 0.00% |
| Bank Of America Corp /De/ | 224,412 | 0.87% | $1.02M | −10,984 | 0.00% |
| Westmount Partners, LLC | 197,178 | 0.76% | $893.22K | +153,858 | 0.20% |
| BlackRock, Inc. | 179,850 | 0.69% | $814.72K | +24,012 | 0.00% |
| Geode Capital Management, LLC | 166,120 | 0.64% | $752.79K | +39,267 | 0.00% |
| Vanguard Fiduciary Trust Co | 91,480 | 0.35% | $414.40K | +35,464 | 0.00% |
| State Street Corp | 43,170 | 0.17% | $195.56K | – | 0.00% |
| Northern Trust Corp | 35,871 | 0.14% | $162.50K | +12,600 | 0.00% |
| Global Retirement Partners, LLC | 27,790 | 0.11% | $125.89K | New | 0.00% |
| Marshall Wace, Llp | 21,784 | 0.08% | $98.68K | +9,206 | 0.00% |
| Morgan Stanley | 15,647 | 0.06% | $70.88K | −36,275 | 0.00% |
| Royal Bank of Canada | 15,625 | 0.06% | $71.00K | −1,000 | 0.00% |
| HCR Wealth Advisors | 15,000 | 0.06% | $67.95K | – | 0.01% |
| Vanguard Global Advisers, LLC | 4,265 | 0.02% | $19.32K | – | 0.00% |
| Ancora Advisors, LLC | 2,075 | 0.01% | $9.40K | – | 0.00% |
| Wells Fargo & Company/Mn | 2,000 | 0.01% | $9.06K | +500 | 0.00% |
| UBS Group AG | 1,731 | 0.01% | $7.84K | +1,458 | 0.00% |
| Strategic Wealth Partners, Ltd. | 492 | 0.00% | $2.23K | – | 0.00% |
| Barclays PLC | 453 | 0.00% | $2.05K | −7,609 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 21 | 3M | 12.2% | 2 / 10 | 4 / 8 | 1M | 1M |
| Q1 2026 | 27 | 3M | 11.2% | 10 / 6 | 5 / 5 | 2M | 1M |
| Q4 2025 | 24 | 2M | 8.2% | 8 / 9 | 3 / 3 | 0M | 0M |
| Q3 2025 | 19 | 2M | 6.9% | 11 / 3 | 3 / 2 | 1M | 0M |
| Q2 2025 | 10 | 1M | 2.4% | 7 / 3 | 0 / 1 | 1M | 0M |
| Q1 2025 | 4 | 0M | 0.2% | 4 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NTHI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 310,603 | 1.20% | $1.41M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 188,181 | 0.73% | $852.46K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 53,986 | 0.21% | $250.50K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 35,402 | 0.14% | $160.37K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 20,677 | 0.08% | $95.94K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 15,729 | 0.06% | $72.98K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 12,122 | 0.05% | $56.25K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 7,100 | 0.03% | $32.16K | 0.02% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 4,845 | 0.02% | $21.95K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 2,351 | 0.01% | $10.65K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 542 | 0.00% | $2.46K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Amir F. Heshmatpour | CEO, President, Director, 10% owner | 7,703,140 | 29.70% | Sep 15, 2026 |
| Thomas C. Chen | CEO, Director, 10% owner | 4,685,586 | 18.07% | Sep 15, 2026 |
| Keithly Garnett | CFO | 281,410 | 1.09% | Sep 18, 2026 |
| Yousha Neman-Ebrahim | Chief Clinical Officer | 134,760 | 0.52% | Apr 24, 2026 |
| Suh, David Jr. | Chief Accounting Officer | 111,866 | 0.43% | Apr 13, 2026 |
| Patrick Walters | COO | 876,373 | 3.38% | Jun 5, 2025 |
| Nasim Shomali | Director | 50,160 | 0.19% | Jul 13, 2026 |
| Ming-Fu (Alan) Chiang | Director | 2,190,049 | 8.44% | Nov 24, 2025 |
| Ishwar Kanwar Puri | Director | – | – | Sep 5, 2025 |
| Jim Delshad | Director | 55,310 | 0.21% | May 19, 2025 |
| Steven L. Giannotta | Director | 50,160 | 0.19% | Mar 28, 2025 |
| Bader Almonawer | Director | 50,160 | 0.19% | Mar 25, 2025 |
| Victoria Medvec | Director | 50,160 | 0.19% | Mar 25, 2025 |
| R. Chen Third Family Limited Partnership T. | 10% owner | 4,586,025 | 17.68% | Mar 25, 2025 |
| AFH Holding & Advisory, LLC | 10% owner | – | – | Mar 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Keithly Garnett CFO | Sep 15, 2026 | Sale(10b5-1 plan) | +5,000 | $3.36 | $16.80K | 237,357 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Sep 15, 2026 | Buy | +35,000 | $3.30 | $115.50K | 3,183,000 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Sep 14, 2026 | Buy | +15,000 | $3.96 | $59.40K | 3,148,000 |
| Thomas C. Chen CEO, Director, 10% owner | Sep 14, 2026 | Buy | +5,242 | $3.82 | $20.02K | 24,503 |
| Keithly Garnett CFO | Sep 14, 2026 | Buy | +257 | $3.89 | $1,000 | 242,357 |
| Thomas C. Chen CEO, Director, 10% owner | Sep 11, 2026 | Buy | +5,556 | $3.60 | $20.00K | 19,261 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Sep 11, 2026 | Buy | +37,000 | $3.67 | $135.79K | 3,133,000 |
| Thomas C. Chen CEO, Director, 10% owner | Aug 18, 2026 | Buy | +12,757 | $5.49 | $70.04K | 13,705 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Aug 18, 2026 | Buy | +9,000 | $5.54 | $49.86K | 3,096,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Aug 17, 2026 | Buy | +2,472 | $4.04 | $9.99K | 583,531 |
| Thomas C. Chen CEO, Director, 10% owner | Aug 17, 2026 | Buy | +2,472 | $4.04 | $9.99K | 583,531 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Aug 17, 2026 | Buy | +3,000 | $4.37 | $13.11K | 3,087,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Aug 14, 2026 | Buy | +33,787 | $3.85 | $130.08K | 581,059 |
| Thomas C. Chen CEO, Director, 10% owner | Aug 14, 2026 | Buy | +33,787 | $3.85 | $130.08K | 581,059 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Aug 14, 2026 | Buy | +12,000 | $3.79 | $45.48K | 3,084,000 |
| Nasim Shomali Director | Jul 10, 2026 | Award | +50,000 | – | – | 50,160 |
| Amir F. Heshmatpour President, Director, 10% owner | May 1, 2026 | Buy | +10,000 | $4.16 | $41.60K | 3,072,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 28, 2026 | Buy | +10,000 | $4.52 | $45.20K | 3,062,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Apr 24, 2026 | Buy | +10,000 | $4.80 | $48.00K | 10,000 |
| Yousha Neman-Ebrahim Chief Clinical Officer | Apr 23, 2026 | Buy | +500 | $4.88 | $2.44K | 134,760 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 23, 2026 | Buy | +10,000 | $4.90 | $49.00K | 3,052,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Apr 10, 2026 | Buy | +948 | $5.17 | $4.90K | 948 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 10, 2026 | Buy | +10,000 | $4.90 | $49.00K | 3,042,000 |
| Suh, David Jr. Chief Accounting Officer | Apr 9, 2026 | Buy | +200 | $5.00 | $1.00K | 111,866 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 9, 2026 | Buy | +5,000 | $5.19 | $25.95K | 3,032,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 8, 2026 | Buy | +10,000 | $5.61 | $56.10K | 3,027,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 6, 2026 | Buy | +5,000 | $6.32 | $31.60K | 3,017,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 2, 2026 | Buy | +20,000 | $6.09 | $121.80K | 3,012,000 |
| Suh, David Jr. Chief Accounting Officer | Mar 1, 2026 | Award | +111,666 | – | – | 111,666 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 24, 2025 | Buy | +6,000 | $6.51 | $39.06K | 2,992,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 21, 2025 | Buy | +4,000 | $6.50 | $26.00K | 2,986,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 21, 2025 | Buy | +20,000 | $5.98 | $119.60K | 2,982,000 |
| Yousha Neman-Ebrahim Chief Clinical Officer | Nov 20, 2025 | Buy | +1,100 | $6.69 | $7.36K | 134,260 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 6, 2025 | Award | +1,200,000 | – | – | 2,962,000 |
| Yousha Neman-Ebrahim Chief Clinical Officer | Jun 5, 2025 | Award | +133,000 | – | – | 133,000 |
| Amir F. Heshmatpour President, Director | May 23, 2025 | Buy | +2,000 | $7.39 | $14.78K | 1,762,000 |
| Thomas C. Chen CEO, Director, 10% owner | May 22, 2025 | Buy | +2,709 | $7.38 | $19.99K | 551,668 |
| Keithly Garnett CFO | May 22, 2025 | Buy | +675 | $7.29 | $4.92K | 240,900 |
| Thomas C. Chen CEO, Director, 10% owner | May 21, 2025 | Buy | +2,759 | $7.25 | $20.00K | 548,959 |
| Keithly Garnett CFO | May 19, 2025 | Buy | +135 | $7.23 | $976 | 240,225 |
| Amir F. Heshmatpour President, Director | May 16, 2025 | Buy | +3,510 | $16.87 | $59.21K | 1,760,000 |
| Amir F. Heshmatpour President, Director | May 15, 2025 | Buy | +1,500 | $7.30 | $10.95K | 1,756,490 |
| Amir F. Heshmatpour President, Director | May 14, 2025 | Buy | +1,000 | $7.27 | $7.27K | 1,754,990 |
| Keithly Garnett CFO | May 13, 2025 | Buy | +90 | $7.01 | $631 | 240,090 |
| Amir F. Heshmatpour President, Director | May 13, 2025 | Buy | +990 | $7.01 | $6.94K | 1,753,990 |
| Keithly Garnett CFO | May 13, 2025 | Buy | −90 | $7.01 | $631 | 330,000 |
| Amir F. Heshmatpour President, Director | May 12, 2025 | Buy | +1,400 | $7.23 | $10.12K | 1,753,000 |
| Jim Delshad Director | May 12, 2025 | Buy | +5,000 | $7.22 | $36.10K | 55,310 |
| Thomas C. Chen CEO, Director, 10% owner | May 12, 2025 | Buy | +400 | $7.00 | $2.80K | 546,200 |
| Amir F. Heshmatpour President, Director | May 11, 2025 | Buy | +1,600 | $7.51 | $12.02K | 1,751,600 |
| Jim Delshad Director | Apr 17, 2025 | Buy | +50 | $6.92 | $346 | 50,310 |
| Keithly Garnett CFO | Apr 15, 2025 | Buy | +300 | $5.38 | $1.61K | 241,200 |
| Patrick Walters COO | Mar 26, 2025 | Sale | −297 | $19.13 | $5.68K | 78,885 |
| Patrick Walters COO | Mar 26, 2025 | Other | −1,231 | – | – | 66,669 |
| Patrick Walters COO | Mar 26, 2025 | Option exercise | +24,063 | $12.00 | $288.76K | 90,732 |
| Patrick Walters COO | Mar 26, 2025 | Sale | −11,550 | $25.00 | $288.75K | 79,182 |
| Ming-Fu (Alan) Chiang Director | Mar 26, 2025 | Sale | −1,446 | $19.13 | $27.66K | 384,180 |
| Ming-Fu (Alan) Chiang Director | Mar 26, 2025 | Option exercise | +117,188 | $12.00 | $1.41M | 441,876 |
| Ming-Fu (Alan) Chiang Director | Mar 26, 2025 | Other | −5,994 | – | – | 324,688 |
| Ming-Fu (Alan) Chiang Director | Mar 26, 2025 | Award | +50,000 | – | – | 390,216 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Garnett Keithly Officer | Sep 15, 2026 | 5,000 | $18.90K | Sep 15, 2026 | Restricted Stock Units |